228
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Application of a quality-by-design approach for utilizing sodium stearyl fumarate as a taste-masking agent in dextromethorphan hydrobromide orally disintegrating tablets

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 711-719 | Received 31 May 2018, Accepted 02 Jan 2019, Published online: 06 Mar 2019

References

  • Aguilar-Díaz JE, García-Montoya E, Suñe-Negre JM, Pérez-Lozano P, Miñarro M, Ticó JR. 2012. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system. Eur J Pharm Biopharm. 80:638–648.
  • Bandari S, Mittapalli RK, Gannu R, Rao YM. 2008. Orodispersible tablets: an overview. Asian J Pharm. 2:2–11.
  • Bandelin FJ. 1989. Compressed tablets by wet granulation. In: Lieberman HA, Lachman L, Schwartz JB, editors. Pharmaceutical dosage forms: tablets. New York: Marcel Dekker; p. 131–194.
  • Berlin CMJ, May-McCarver DG, Notterman DA, Ward RM, Weismann DN, Wilson GS, Wilson JT, Bennett DR, Hoskins IA, Kaufman P, et al. 1997. Alternative routes of drug administration–advantages and disadvantages (subject review). Committee on Drugs. Am Acad Pediatr. 100:143–152.
  • El Maghraby GM, Elzayat EM, Alanazi FK. 2014. Investigation of in situ gelling alginate formulations as a sustained release vehicle for co-precipitates of dextromethrophan and Eudragit S 100. Acta Pharm. 64:29–44.
  • FDA guidelines. 2008. Guidance for industry: orally disintegrating tablets. USA: FDA. [accessed 2018 Jan 01]. https://www.fda.gov/downloads/Drugs/…/Guidances/ucm070578.pdf.
  • Florey K. 1976. Analytical profiles of drug substances. Vol. 5. New York: Academic Press.
  • John KT. 2014. Comparison of Directly Compressible Drug Delivery Systems for Orally Disintegrating Tablets. [accessed 2018 Jan 01]. https://www.spipharma.com/media/2481/comparison-of-directly-compressible-drug-delivery-systems-for-orally-disintegrating-tablets-application-data-sheet.pdf.
  • Kanugo AK, Mathur VB. 2013. Evaluation and comparison of highly soluble sodium stearyl fumarate with other lubricants in-vitro. Indo Am J Pharm Res. 5:4042–4049.
  • Kuccherkar BS, Badhan AC, Mahajan HS. 2003. Mouth dissolving tablets: a novel drug delivery system. Pharm Times. 35:3–10.
  • Kuno Y, Kojima M, Nakagami H, Yonemochi E, Terada K. 2008. Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol. Eur J Pharm Biopharm. 69:986–992.
  • Li J, Wu Y. 2014. Lubricants in pharmaceutical solid dosage forms. Lubricants. 2:21–43.
  • Morin G, Briens L. 2013. The effect of lubricants on powder flowability for pharmaceutical application. AAPS PharmSciTech. 14:1158–1168.
  • Mostafa HF, Ibrahim MA, Sakr A. 2013. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables. Pharm Dev Technol. 18:454–463.
  • Porter SC. 2001. Novel drug delivery: review of recent trends with oral solid dosage forms. Am Pharm Rev. 85:28–35.
  • Sastry SV, Nyshadham JR, Fix JA. 2000. Recent technological advances in oral drug delivery – a review. Pharm Sci Technol Today. 3:138–145.
  • Sharma D. 2013. Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate for respiratory disorders. ISRN Pharm. 2013:674507.
  • Shawn DH, McGuigan MA. 1984. Poisoning from dermal absorption of promethazine. Can Med Assoc J. 130:1460.
  • Sheth BB, Bandelin FJ, Shangraw RF. 1980. Compressed tablets. In: Lieberman HA, Lachman L, editors. Pharmaceutical dosage forms: tablets. New York: Marcel Dekker; p. 109–185.
  • Shoukri RA, Ahmed IS, Shamma RN. 2009. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm. 73:162–171.
  • SPI Pharma. 2016. Lubripharm® SSF. [accessed 2018 Jan 01]. https://www.spipharma.com/media/2382/lubripharm-ssf-product-sales-bulletin.pdf.
  • Umit C, Ali T, Tuba Y, Yucel D, Inventors; SANOVEL, LACSANAY VETICARET ANONIMSIRKETI, assignee. 2010. Orally disintegrating olanzapine tablet. US 201002728.00A1; [accessed 2018 Jan 01]. https://www.spipharma.com/media/2382/lubripharm-ssf-product-sales-bulletin.pdf.
  • USP30-NF25. 2007. The United States pharmacopoeia-the national formulary. Rockville, MD, 20852: The United States Pharmacopoeial Convention, Inc.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.